Prehabilitation of Elderly Patients With Frailty Syndrome Before Elective Surgery (PRAEP-GO)

NCT ID: NCT04418271

Last Updated: 2025-02-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

1199 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-06-30

Study Completion Date

2024-12-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to evaluate the effect of a shared decision-making conference and three-week prehabilitation program on the outcome "care dependency" one year after surgery. The cost-effectiveness of the intervention will also be evaluated in this N = 1400 patient, national multicenter, assessor-blinded, randomized, pragmatic, controlled, parallel-group, clinical trial.

The objective of PRÄP-GO is to establish and employ a suitable preoperative case-care management system to improve the short and long-term outcome of elderly surgical patients with signs of a frailty syndrome, improving postoperative quality of life and reducing care dependency by a three-week individualized prehabilitation program.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Frailty Frail Elderly

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Patients with frailty syndrome (≥1 of the standardized parameters (Pre-Frail = 1-2; Frail≥3) according to Fried et al.(2001) are offered randomised participation in the new form of care.
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Prehabilitation

Prefrail and frail patients receive prehabilitation (new form of care)

Group Type EXPERIMENTAL

Prehabilitation- new form of care

Intervention Type BEHAVIORAL

The participants in the intervention group take part in a shared decision-making (SDM) conference to plan the intervention. The therapeutic content of the prehabilitation is defined individually for each patient in the SDM conference. Prehabilitation will be a structured and individually tailored 3-week program.

Standard of Care

Prefrail and frail patients receive no prehabilitation, but receive standard of care

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Prehabilitation- new form of care

The participants in the intervention group take part in a shared decision-making (SDM) conference to plan the intervention. The therapeutic content of the prehabilitation is defined individually for each patient in the SDM conference. Prehabilitation will be a structured and individually tailored 3-week program.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 70 years
* Consent by Patient or Legal Representative
* Elective surgery planned
* Expected anesthesia duration≥ 60 min
* Statutory health insurance
* Frailty syndrome (≥1 positive out of 5 standardized parameters according to the Physical Frailty Phenotype according to Fried et. al.)

Exclusion Criteria

* Severe cardiac or pulmonary disease (NYHA IV, Gold IV)
* Intracranial interventions
* Moribund patients (palliative situation)
* Not enough language skills
* Participation in another interventional rehabilitation study or other interventional clinical trial that has not been approved by the study management committee (Exception: Participation in adjuvant intervention study)
Minimum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ludwig-Maximilians - University of Munich, The Institute for Medical Information Processing, Biometry, and Epidemiology

UNKNOWN

Sponsor Role collaborator

Technische Universität Berlin

OTHER

Sponsor Role collaborator

BARMER

OTHER

Sponsor Role collaborator

Charite University, Berlin, Germany

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Claudia Spies

Univ.- Prof. Dr. Claudia Spies

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Claudia Spies, Prof., MD

Role: STUDY_CHAIR

Charite University, Berlin, Germany

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Herz- und Diabetes Zentrum

Bad Oeynhausen, , Germany

Site Status

Department of Anesthesiology and Operative Intensive Care Medicine (CBF), Charité - Universitätsmedizin Berlin

Berlin, , Germany

Site Status

Department of Anesthesiology and Operative Intensive Care Medicine CCM/CVK, Charité - Universitätsmedizin Berlin

Berlin, , Germany

Site Status

Auguste-Viktoria-Klinikum - Vivantes - Netzwerk für Gesundheit GmbH

Berlin, , Germany

Site Status

Bundeswehrkrankenhaus

Berlin, , Germany

Site Status

CARITAS Klinik Maria Heimsuchung

Berlin, , Germany

Site Status

Dominikus-Krankenhaus

Berlin, , Germany

Site Status

Evangelisches Krankenhaus Hubertus

Berlin, , Germany

Site Status

Humboldt-Klinikum - Vivantes - Netzwerk für Gesundheit GmbH

Berlin, , Germany

Site Status

Klinikum im Friedrichshain - Vivantes - Netzwerk für Gesundheit GmbH

Berlin, , Germany

Site Status

Martin-Luther-Krankenhaus

Berlin, , Germany

Site Status

Sankt Joseph Krankenhaus

Berlin, , Germany

Site Status

Unfallkrankenhaus Berlin

Berlin, , Germany

Site Status

Klinikum Frankfurt Oder GmbH

Frankfurt (Oder), , Germany

Site Status

Universitätsmedizin Greifswald

Greifswald, , Germany

Site Status

Universitätsklinikum Hamburg-Eppendorf

Hamburg, , Germany

Site Status

Sana Kliniken Sommerfeld

Kremmen, , Germany

Site Status

Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Universität zu Lübeck

Lübeck, , Germany

Site Status

Klinikum der Universität München, LMU Campus Großhadern

München, , Germany

Site Status

Klinikum rechts der Isar - Technische Universität München

München, , Germany

Site Status

München Klinik Bogenhausen

München, , Germany

Site Status

Havelland Kliniken GmbH - Klinik Nauen

Nauen, , Germany

Site Status

Havelland Kliniken-Klinik Rathenow

Rathenow, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

References

Explore related publications, articles, or registry entries linked to this study.

Eckhardt H, Quentin W, Silzle J, Busse R, Rombey T. Cost-effectiveness of prehabilitation of elderly frail or pre-frail patients prior to elective surgery (PRAEP-GO) versus usual care - Protocol for a health economic evaluation alongside a randomized controlled trial. BMC Geriatr. 2024 Mar 6;24(1):231. doi: 10.1186/s12877-024-04833-5.

Reference Type DERIVED
PMID: 38448804 (View on PubMed)

Schaller SJ, Kiselev J, Loidl V, Quentin W, Schmidt K, Morgeli R, Rombey T, Busse R, Mansmann U, Spies C; PRAEP-GO consortium,; PRAEP-GO investigators. Prehabilitation of elderly frail or pre-frail patients prior to elective surgery (PRAEP-GO): study protocol for a randomized, controlled, outcome assessor-blinded trial. Trials. 2022 Jun 6;23(1):468. doi: 10.1186/s13063-022-06401-x.

Reference Type DERIVED
PMID: 35668532 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

U1111-1253-4820

Identifier Type: OTHER

Identifier Source: secondary_id

PRAEP-GO

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

PREPA PREvention of Loss of Autonomy
NCT03667664 ACTIVE_NOT_RECRUITING NA